Showing results (151-160 of 1,361) with videos related to
Sort By:
Pageof 137
Drugs Under Experimental and Clinical Research|January 1, 1994
Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infectionsI Hayashi, M Inoue, H HashimotoDrugs Under Experimental and Clinical Research|January 1, 1994
Biliary elimination and hepatic disposition of an association of piperacillin and tazobactam: experimental evaluationJ M Brogard, F Caro-Sampara, J F Westphal, et al.Drugs Under Experimental and Clinical Research|January 1, 1994
Interaction of cefdinir with beta-lactamasesR Labia, A MorandDrugs Under Experimental and Clinical Research|January 1, 1988
Pretreatment with ICRF-187 allows a marked increase in the total cumulative dose of doxorubicin tolerated by beagle dogsE H Herman, V J Ferrans, R S Young, et al.Drugs Under Experimental and Clinical Research|January 1, 1986
Comparative in vitro studies on cefotaxime and desacetylcefotaximeS Selwyn, M BakhtiarDrugs Under Experimental and Clinical Research|January 1, 1988
Inhibition of human immunodeficiency virus-associated reverse transcriptase by aminoacridinesS Atsumi, Y Muraoka, T Nogami, et al.Drugs Under Experimental and Clinical Research|July 24, 1998
New steroidal antiinflammatory agents: prednisolone derivatives with an isoxazoline fusion at the 16- and 17-carbons and an alkyl carboxylate at the 16 alpha-positionH J Lee, Z You, D H Ko, et al.Drugs Under Experimental and Clinical Research|July 24, 1998
Suppressive effects of the new antirheumatic drug KE-298 on TNF alpha-induced production of matrix metalloproteinases but not of tissue inhibitor-1 of metalloproteinases in human rheumatoid synoviocytesS Takahashi, T Inoue, M Higaki, et al.Drugs Under Experimental and Clinical Research|February 11, 2005
Hepatoprotective properties of Commiphora opobalsamum ("Balessan"), a traditional medicinal plant of Saudi ArabiaT A Al-Howiriny, M O Al-Sohaibani, M S Al-Said, et al.Drugs Under Experimental and Clinical Research|February 11, 2005
Topical treatment of partial thickness burns by silver sulfadiazine plus hyaluronic acid compared to silver sulfadiazine alone: a double-blind, clinical studyJ KollerPageof 137